Pitfalls in the preoperative and postoperative workup of patients with primary aldosteronism
Marta Araujo-Castro,Iñigo García Sanz
DOI: https://doi.org/10.21037/gs-23-482
2024-03-28
Gland Surgery
Abstract:Marta Araujo-Castro 1,2 , Iñigo García Sanz 3,4 1 Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, Madrid, Spain; 2 Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain; 3 General & Digestive Surgery Department, Hospital Universitario de La Princesa, Madrid, Spain; 4 Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, Spain Comment on: Vignaud T, Baud G, Nominé-Criqui C, et al . Surgery for Primary Aldosteronism in France From 2010 to 2020 - Results from the French-Speaking Association of Endocrine Surgery (AFCE): Eurocrine Study Group. Ann Surg 2023;278:717-24. Keywords: Primary aldosteronism (PA); adrenal venous sampling (AVS); adrenalectomy Submitted Nov 24, 2023. Accepted for publication Feb 01, 2024. Published online Mar 22, 2024. doi: 10.21037/gs-23-482 We were highly interested in the findings of Vignaud et al. 's study (1), which showed that preoperative workup was consistent with guidelines for only 40% of the patients with primary aldosteronism (PA). In addition, they found that complete biological success was not sufficiently assessed after surgery, and no differences in surgical outcomes were observed between patients operated based on the results of adrenal computed tomography (CT) scanning or adrenal venous sampling (AVS). It is known that PA is the most frequent cause of endocrine arterial hypertension and it is associated with a higher cardiometabolic risk than primary hypertension (2,3). However, despite its importance, PA remains highly underdiagnosed (4), and the PA management guidelines are poorly applied for its detection and management (2,3). At the moment, the real-life situation is that only 1.9% of the expected cases of PA are diagnosed and as a consequence, just 1% of the expected adrenalectomies are performed (4). In addition, discrepant recommendations were identified at all management steps (screening, confirmation, classification, treatment and follow-up) among 12 guidelines for the diagnosis and treatment of PA, published between 2006 and 2016 (5). In terms of the preoperative work-up, no consensus exists about which aldosterone to renin ratio should be used for PA screening, nor what confirmatory test is the most reliable to confirm autonomous aldosterone secretion (2,3). Nevertheless, as Vignaud et al. (1)highlighted,the most challenging diagnostic step is the subtyping of PA since CT and magnetic resonance imaging (MRI) are considered unreliable procedures to differentiate between unilateral and bilateral PA, with a reported discordance between these techniques and AVS of 38% (6). Thus, the last guidelines recommend that when surgical treatment is desired by the patient, an experienced radiologist should use an AVS to make the distinction between unilateral and bilateral disease (3). The exceptions proposed by the guidelines for performing AVS are to suspect an adrenocortical carcinoma, cortisol co-secretion or an age <35 years old and clear unilateral adrenal nodule in CT/MRI (2,3). However, there is a gap between clinical guidelines recommendations and current clinical practice. In this regard, as it has been reported by Vignaud et al. (1), only 31% of the patients with PA underwent AVS before surgery and preoperative AVS was "adequately" performed in just 40% of the cases (2,3). These results are in agreement with the described in the SPAIN-ALDO study, where only 35% of the patients had an available AVS (7). The criteria for using AVS are quite heterogeneous across centers. For example, in the Vignaud series (1), some centers hardly ever used the procedure, others limited AVS use to specific situations such as bilateral lesions on imaging, small lesions on imaging or large number of preoperative antihypertensive treatments, and others followed strictly the French recommendations. Nonetheless, in this study, there was no correlation between complete clinical success and the completeness of preoperative workup. These results are in line with the described in the unique prospective randomized study published comparing CT-based and AVS-based management (8). However, we have to take into account that SPARTACUS study has several limitations, including that they selected the most severe group of patients with PA; the four cases in whom AVS failed were included in the CT cohort; the difficulties in reconciling CT diagnoses between cooperating institutions and the study was not generated to evaluate secondary endpoints (hypertension cure and biochemical cure) (8). Other factors that may justify the existence of a heterogenous use of AVS is the lack of consensus about which is the best approach in the AVS: (I) some authors defend the use of adreno -Abstract Truncated-
surgery